Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

Clinical trial NCT01649427 · COMPLETED

Trial details

NCT number: NCT01649427
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pharmacokinetics Study in de Novo Kidney Transplantation

Start date: 2012-10-17
Primary completion: 2015-08-20
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.